Search
for
Sort by
Research 481–510 of 1000+
- Activation of the integrated stress response in human hair follicles
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Efficient expansion of human keratinocyte stem/progenitor cells carrying a transgene with lentiviral vector
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- PCSK9: From Nature’s Loss to Patient’s Gain
- Recent advances in the epidermal growth factor receptor/ligand system biology on skin homeostasis and keratinocyte stem cell regulation
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Application of Baricitinib in Dermatology
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- Alopecia areata – Current understanding and management
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- What is behind the ‘swarm of bees’ in alopecia areata
- Prostaglandins and Skin Cancer: An Old Pathway With New Insights in Cutaneous Oncology
- Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin
- Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses